On Apr. 2, 2025, KNY LEG reported bill approval as Act 158, effective Jun. 26, 2025.
On Mar. 28, KNY LEG passed bill to require screenings and lab tests.
KNY LEG passed bill HB 421 to require coverage for colorectal cancer examinations.
Also, for lab tests specified in the United States Multi-Society Task Force on Colorectal Cancer guidelines for certain covered persons; bill amends KNY INS 304.17A-257.
Bill Provisions
Requires coverage for all United States Food and Drug Administration-approved bowel preparation prescribed in connection with a colorectal cancer examination or test.
Prohibits prior authorization requirements for colorectal examinations and lab tests.
In addition, bill provides an exemption from the cost sharing prohibition for Health Savings Account-qualified High Deductible Health Plans under certain circumstances.
Also, provides that the colorectal cancer examination and laboratory test coverage section applies to health benefit plans issued or renewed on or after January 1, 2026.
Constructs certain provisions for purposes of federal law, requires State to comply.
Requires the Cabinet for Health and Family Services or the Department for Medicaid Services to obtain federal approval, if necessary and comply with notice requirements.
Legislative History
On Feb. 11, 2025, bill was introduced in House; on Mar. 5, 2025, bill passed in House.
On Mar. 6, 2025, bill was introduced in Senate; on Mar. 28, 2025, bill passed Senate.
Effectiveness
If approved, effective 90 days after official end of session, scheduled Mar. 28, 2025.
In addition, Sections 1 and 2 of this act take effect on Jan. 1, 2026.
Apr. 2025 KNY LEG Bill Approval
On Apr. 2, 2025, KNY LEG reported bill approval as Act 158, effective Jun. 26, 2025.
Regulators
KNY LEG
Entity Types
Ins
Reference
PR, Act 158, Bill HB421, 4/2/2025; Bill HB421, 3/28/2025; Citation: KNY INS 304.17A-257;
